Showing results (1071-1080 of 1,797) with videos related to

Sort By:
Pageof 180
Mabs|June 22, 2022
Antigenic landscapes on Staphylococcus aureus pore-forming toxins reveal insights into specificity and cross-neutralizationShweta Kailasan, Ravi Kant, Madeleine Noonan-Shueh, et al.
Mabs|July 8, 2022
Mechanistic insights into the rational design of masked antibodiesCarolina T Orozco, Manuela Bersellini, Lorraine M Irving, et al.
Mabs|June 2, 2021
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitroHaolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
Mabs|February 15, 2020
Anti-ErbB2 immunotherapeutics: struggling to make better antibodies for cancer therapyRita De Santis
Mabs|February 18, 2020
10th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsS Tourdot, A Abdolzade-Bavil, J Bessa, et al.
Mabs|January 31, 2020
Improved translation of stability for conjugated antibodies using an in vitro whole blood assayAimee Fourie-O'Donohue, Phillip Y Chu, Josefa Dela Cruz Chuh, et al.
Mabs|June 12, 2021
Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodiesBoris Grinshpun, Nels Thorsteinson, Joao Ns Pereira, et al.
Mabs|April 17, 2015
Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1Gang Chen, Leonid Gorelik, Kenneth J Simon, et al.
Mabs|July 21, 2020
COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumorsAnand Panchal, Pui Seto, Russell Wall, et al.
Mabs|April 14, 2023
Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality controlFeng Yang, Jennifer Zhang, Alexander Buettner, et al.
Pageof 180